Filed: 11/14/2022ACC: 0001104659-22-118489
📋 What this filing means
NEXTECH INVEST LTD. filed this quarterly 13F‑HR report disclosing 14 equity positions with a total reported market value of $309.6K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
14
Positions
$309.6K
Total AUM (reported)
30.64M
Total Shares
Allocation by class
COM$306.3K98.9%
COM STK$3.3K1.1%
Portfolio Concentration
Top 3$179.3K57.9%
4–10$108.5K35.1%
11–25$21.8K7.0%
Top 3 weight
57.9%
Top 10 weight
93.0%
Voting Authority Distribution
Total shares with voting rights: 30.64M
Sole
Full voting authority
30.64M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole14
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings14
Rows:
REVOLUTION MEDICINES INC
SOLEShares4.19M
TypeSH
Market value$82.6K
26.68%
Sole
4.19M
Shared
0.00
None
0.00
EQRX INC
SOLEShares13.10M
TypeSH
Market value$64.9K
20.95%
Sole
13.10M
Shared
0.00
None
0.00
KINNATE BIOPHARMA INC
SOLEShares2.66M
TypeSH
Market value$31.8K
10.27%
Sole
2.66M
Shared
0.00
None
0.00
TYRA BIOSCIENCES INC
SOLEShares2.52M
TypeSH
Market value$22.1K
7.15%
Sole
2.52M
Shared
0.00
None
0.00
MIRATI THERAPEUTICS INC
SOLEShares263.91K
TypeSH
Market value$18.4K
5.95%
Sole
263.91K
Shared
0.00
None
0.00
PMV PHARMACEUTICALS INC
SOLEShares1.39M
TypeSH
Market value$16.5K
5.33%
Sole
1.39M
Shared
0.00
None
0.00
CULLINAN ONCOLOGY INC
SOLEShares1.22M
TypeSH
Market value$15.7K
5.06%
Sole
1.22M
Shared
0.00
None
0.00
ARVINAS INC
SOLEShares287.25K
TypeSH
Market value$12.8K
4.13%
Sole
287.25K
Shared
0.00
None
0.00
BLUEPRINT MEDICINES CORP
SOLEShares188.23K
TypeSH
Market value$12.4K
4.01%
Sole
188.23K
Shared
0.00
None
0.00
RELAY THERAPEUTICS INC
SOLEShares475.49K
TypeSH
Market value$10.6K
3.44%
Sole
475.49K
Shared
0.00
None
0.00
SILVERBACK THERAPEUTICS INC
SOLEShares1.91M
TypeSH
Market value$10.1K
3.26%
Sole
1.91M
Shared
0.00
None
0.00
KRONOS BIO INC
SOLEShares1.45M
TypeSH
Market value$4.9K
1.57%
Sole
1.45M
Shared
0.00
None
0.00
THESEUS PHARMACEUTICALS INC
SOLEShares611.31K
TypeSH
Market value$3.5K
1.15%
Sole
611.31K
Shared
0.00
None
0.00
C4 THERAPEUTICS INC
SOLEShares375.86K
TypeSH
Market value$3.3K
1.06%
Sole
375.86K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
REVOLUTION MEDICINES INCSOLE | COM | 4.19M | SH | $82.6K 26.68% | 4.19M | 0.00 | 0.00 |
EQRX INCSOLE | COM | 13.10M | SH | $64.9K 20.95% | 13.10M | 0.00 | 0.00 |
KINNATE BIOPHARMA INCSOLE | COM | 2.66M | SH | $31.8K 10.27% | 2.66M | 0.00 | 0.00 |
TYRA BIOSCIENCES INCSOLE | COM | 2.52M | SH | $22.1K 7.15% | 2.52M | 0.00 | 0.00 |
MIRATI THERAPEUTICS INCSOLE | COM | 263.91K | SH | $18.4K 5.95% | 263.91K | 0.00 | 0.00 |
PMV PHARMACEUTICALS INCSOLE | COM | 1.39M | SH | $16.5K 5.33% | 1.39M | 0.00 | 0.00 |
CULLINAN ONCOLOGY INCSOLE | COM | 1.22M | SH | $15.7K 5.06% | 1.22M | 0.00 | 0.00 |
ARVINAS INCSOLE | COM | 287.25K | SH | $12.8K 4.13% | 287.25K | 0.00 | 0.00 |
BLUEPRINT MEDICINES CORPSOLE | COM | 188.23K | SH | $12.4K 4.01% | 188.23K | 0.00 | 0.00 |
RELAY THERAPEUTICS INCSOLE | COM | 475.49K | SH | $10.6K 3.44% | 475.49K | 0.00 | 0.00 |
SILVERBACK THERAPEUTICS INCSOLE | COM | 1.91M | SH | $10.1K 3.26% | 1.91M | 0.00 | 0.00 |
KRONOS BIO INCSOLE | COM | 1.45M | SH | $4.9K 1.57% | 1.45M | 0.00 | 0.00 |
THESEUS PHARMACEUTICALS INCSOLE | COM | 611.31K | SH | $3.5K 1.15% | 611.31K | 0.00 | 0.00 |
C4 THERAPEUTICS INCSOLE | COM STK | 375.86K | SH | $3.3K 1.06% | 375.86K | 0.00 | 0.00 |